Immune-mediated dormancy: an equilibrium with cancer.
J Leukoc Biol
; 84(4): 988-93, 2008 Oct.
Article
em En
| MEDLINE
| ID: mdl-18515327
This brief review discusses the role of the immune system in tumor development, covering a history of cancer immunity and a summary of the concept of cancer immunoediting, including its three phases: elimination, equilibrium, and escape. The latter half of this review then focuses specifically on the equilibrium phase, making note of previous work, suggesting that immunity might maintain cancer in a dormant state, and concluding with a description of a tractable mouse model unequivocally demonstrating that immunity can indeed hold preformed cancer in check. These findings form a framework for future studies aimed at validating immune-mediated cancer dormancy in humans with the hopes of devising new, immunotherapeutic strategies to treat established cancer.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Evasão Tumoral
/
Sistema Imunitário
/
Neoplasias
Idioma:
En
Ano de publicação:
2008
Tipo de documento:
Article
País de afiliação:
Austrália